Although expanded NK cells were able to kill CD34 + CML cells, no enhanced cell killing was noted with TIM3 blockade in CD34+ cells or leukemic stem cells CD34 + CD38- cells (Supplementary Fig. 10d). This evidence concerns the gene HAVCR2 and chronic myelogenous leukemia, BCR-ABL1 positive.